A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

BACKGROUND: Long-acting muscarinic antagonist/long-acting β(2)-agonist combinations are recommended for patients whose chronic obstructive pulmonary disease (COPD) is not managed with monotherapy. We assessed the efficacy and safety of glycopyrrolate (GP)/formoterol fumarate (FF) fixed-dose combinat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Respir Res
Main Authors: Reisner, Colin, Fabbri, Leonardo M., Kerwin, Edward M., Fogarty, Charles, Spangenthal, Selwyn, Rabe, Klaus F., Ferguson, Gary T., Martinez, Fernando J., Donohue, James F., Darken, Patrick, St. Rose, Earl, Orevillo, Chad, Strom, Shannon, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216561/
https://ncbi.nlm.nih.gov/pubmed/28061907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0491-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki